Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-12-001627
Filing Date
2012-11-14
Accepted
2012-11-14 10:32:01
Documents
7
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 409273
  Complete submission text file 0001493152-12-001627.txt   2269409

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE vnth-20120930.xml EX-101.INS 180994
3 XBRL SCHEMA FILE vnth-20120930.xsd EX-101.SCH 29164
4 XBRL CALCULATION FILE vnth-20120930_cal.xml EX-101.CAL 43001
5 XBRL DEFINITION FILE vnth-20120930_def.xml EX-101.DEF 60920
6 XBRL LABEL FILE vnth-20120930_lab.xml EX-101.LAB 189630
7 XBRL PRESENTATION FILE vnth-20120930_pre.xml EX-101.PRE 137368
Mailing Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064
Business Address 11400 OLYMPIC BLVD., SUITE 640 LOS ANGELES CA 90064 310-477-5811
Vantage Health (Filer) CIK: 0001497130 (see all company filings)

EIN.: 980659770 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-168930 | Film No.: 121201607
SIC: 2834 Pharmaceutical Preparations